Nuwellis Inc Quick Ratio (NUWE) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Nuwellis Inc   (NASDAQ: NUWE)

Nuwellis Inc 's Quick Ratio

NUWE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Nuwellis Inc 's Cash & cash equivalent grew by 88.29 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Nuwellis Inc 's Quick Ratio to 0.98, Quick Ratio remained below Nuwellis Inc average.

Within Medical Equipment & Supplies industry 110 other companies have achieved higher Quick Ratio than Nuwellis Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1835, from total ranking in the first quarter 2026 at 2208.

Explain Quick Ratio?
How much Cash & cash equivalents NUWE´s has?
What are NUWE´s Current Liabilities?




NUWE Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 2.98 % 35.69 % 4.96 % 30.4 % -3.09 %
Y / Y Cash & cash equivalent Change -11.87 % -18.54 % -78.7 % 62.24 % 335 %
Quick Ratio MRQ 0.98 0.56 0.4 0.88 1.14
NUWE's Total Ranking # 1835 # 2208 # 1547 # 1342 #
Seq. Current Liabilities Change 7.45 % 38.87 % -23.74 % -9.51 % 41.58 %
Seq. Cash & cash equivalent Change 88.29 % 91.98 % -64.93 % -30.47 % 74.03 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 629
Overall Market # 1835


Quick Ratio Statistics
High Average Low
20.26 4.58 0.25
(Sep 30 2013)   (Jun 30 2024)




Financial Statements
Nuwellis Inc 's Current Liabilities $ 4 Millions Visit NUWE's Balance sheet
Nuwellis Inc 's Cash & cash equivalent $ 4 Millions Visit NUWE's Balance sheet
Source of NUWE's Sales Visit NUWE's Sales by Geography


Cumulative Nuwellis Inc 's Quick Ratio

NUWE's Quick Ratio for the trailling 12 Months

NUWE Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 17.18 % 15.01 % -5.52 % -10.48 % -17.94 %
Y / Y Cash & cash equivalent TTM Growth -27.3 % 1.23 % 18.68 % 86.91 % 25.61 %
Quick Ratio TTM 0.73 0.77 0.87 1.19 1.18
Total Ranking TTM # 4074 # 3163 # 3211 # 3000 #
Seq. Current Liabilities TTM Growth 0.84 % 7.63 % 1 % 6.9 % -1.03 %
Seq. Cash & cash equivalent TTM Growth -4.93 % -4.24 % -26.39 % 8.47 % 32.39 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $4.01 millions, cumulative Quick Ratio decreased to 0.73 below the Nuwellis Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Nuwellis Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3163 to 4074.

Explain Quick Ratio?
How much Cash & cash equivalents NUWE´s has?
What are NUWE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 907
Within the Market # 4074


trailing twelve months Quick Ratio Statistics
High Average Low
17 4.75 0.57
(Jun 30 2014)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Edwards Lifesciences Corporation  2.68 $ 4,291.700  Millions$ 1,604.100  Millions
Modular Medical Inc  2.63 $ 3.920  Millions$ 1.489  Millions
Co diagnostics Inc   2.55 $ 7.299  Millions$ 2.863  Millions
Staar Surgical Co  2.47 $ 181.489  Millions$ 73.394  Millions
Electromed Inc   2.35 $ 20.450  Millions$ 8.714  Millions
EBR Systems, Inc.  2.18 $ 113.533  Millions$ 52.023  Millions
Medinotec Inc   2.15 $ 2.519  Millions$ 1.171  Millions
Atricure Inc   2.05 $ 167.786  Millions$ 81.916  Millions
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions

Date modified: 2026-09-03T12:04:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.